Bo Bin Lee

828 total citations
22 papers, 621 citations indexed

About

Bo Bin Lee is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bo Bin Lee has authored 22 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Bo Bin Lee's work include Epigenetics and DNA Methylation (15 papers), Cancer-related gene regulation (12 papers) and RNA modifications and cancer (8 papers). Bo Bin Lee is often cited by papers focused on Epigenetics and DNA Methylation (15 papers), Cancer-related gene regulation (12 papers) and RNA modifications and cancer (8 papers). Bo Bin Lee collaborates with scholars based in South Korea and United States. Bo Bin Lee's co-authors include Duk-Hwan Kim, Young Mog Shim, Joobae Park, Joungho Han, Eun Ju Lee, Yujin Kim, Sang Yong Song, Dong K. Chang, Ho-Kyung Chun and Eun Yoon Cho and has published in prestigious journals such as Cancer, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Bo Bin Lee

21 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Bin Lee South Korea 15 502 190 149 95 88 22 621
Sylvie Rothhut France 12 422 0.8× 159 0.8× 150 1.0× 144 1.5× 43 0.5× 14 548
Li-Ru He China 14 422 0.8× 189 1.0× 170 1.1× 94 1.0× 29 0.3× 19 591
Slavomir Dzieciatkowski United States 10 420 0.8× 188 1.0× 298 2.0× 86 0.9× 281 3.2× 12 651
Ella Liberzon Israel 8 313 0.6× 278 1.5× 111 0.7× 177 1.9× 45 0.5× 9 529
Jennifer Hanson Canada 11 294 0.6× 270 1.4× 206 1.4× 103 1.1× 71 0.8× 20 562
Jill N. Vilaythong United States 2 336 0.7× 135 0.7× 139 0.9× 38 0.4× 127 1.4× 2 469
Mariangela Balistreri Italy 10 270 0.5× 219 1.2× 124 0.8× 89 0.9× 46 0.5× 15 487
Songwang Cai China 13 315 0.6× 186 1.0× 154 1.0× 66 0.7× 43 0.5× 33 516
Zsófia Brigitta Nagy Hungary 15 439 0.9× 405 2.1× 157 1.1× 81 0.9× 139 1.6× 42 641

Countries citing papers authored by Bo Bin Lee

Since Specialization
Citations

This map shows the geographic impact of Bo Bin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Bin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Bin Lee more than expected).

Fields of papers citing papers by Bo Bin Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Bin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Bin Lee. The network helps show where Bo Bin Lee may publish in the future.

Co-authorship network of co-authors of Bo Bin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Bin Lee. A scholar is included among the top collaborators of Bo Bin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Bin Lee. Bo Bin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Bo Bin, et al.. (2023). Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells. Clinical Epigenetics. 15(1). 48–48. 9 indexed citations
2.
Lee, Bo Bin, et al.. (2022). Aberrant Methylation of SLIT2 Gene in Plasma Cell-Free DNA of Non-Small Cell Lung Cancer Patients. Cancers. 14(2). 296–296. 5 indexed citations
3.
Kim, Dongho, Yujin Kim, Bo Bin Lee, et al.. (2021). Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells. Cancers. 13(4). 739–739. 14 indexed citations
4.
Kim, Dohun, Yujin Kim, Bo Bin Lee, et al.. (2020). Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 9(10). 3067–3067.
5.
Kim, Yujin, Bo Bin Lee, Dongho Kim, et al.. (2020). Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 9(6). 1694–1694. 16 indexed citations
6.
Lee, Bo Bin, Yujin Kim, Dongho Kim, et al.. (2019). Metformin and tenovin‐6 synergistically induces apoptosis through LKB1‐independent SIRT1 down‐regulation in non‐small cell lung cancer cells. Journal of Cellular and Molecular Medicine. 23(4). 2872–2889. 33 indexed citations
7.
Um, Sang‐Won, Yujin Kim, Bo Bin Lee, et al.. (2018). Genome-wide analysis of DNA methylation in bronchial washings. Clinical Epigenetics. 10(1). 65–65. 20 indexed citations
8.
Um, Sang‐Won, Hong Kwan Kim, Yujin Kim, et al.. (2017). Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer. Clinical Epigenetics. 9(1). 131–131. 18 indexed citations
9.
Kim, Yujin, Donghao Jin, Bo Bin Lee, et al.. (2016). Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy. Journal of Thoracic Oncology. 11(12). 2193–2201. 14 indexed citations
10.
Lee, Eun‐Ju, Donghao Jin, Bo Bin Lee, et al.. (2015). Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro. BMC Cancer. 15(1). 982–982. 15 indexed citations
11.
Kim, Yujin, Donghao Jin, Bo Bin Lee, et al.. (2015). RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung. Clinical Epigenetics. 7(1). 32–32. 6 indexed citations
12.
Lee, Bo Bin, Yujin Kim, Seung‐Hyun Hong, et al.. (2014). HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non‐small cell lung cancer. Molecular Carcinogenesis. 54(S1). E72–80. 39 indexed citations
13.
Lee, Bo Bin, Yujin Kim, Eun Ju Lee, et al.. (2013). Association of RASSF1A and p63 with Poor Recurrence-Free Survival in Node-Negative Stage I–II Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(5). 1204–1212. 24 indexed citations
14.
Lee, Eun‐Ju, Bo Bin Lee, Yujin Kim, et al.. (2013). Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence‐related prognostic indicator in stage I esophageal squamous cell carcinoma. Cancer. 119(9). 1752–1760. 9 indexed citations
15.
Hwang, Jung-Ah, Bo Bin Lee, Yujin Kim, et al.. (2013). HOXA11 hypermethylation is associated with progression of non-small cell lung cancer. Oncotarget. 4(12). 2317–2325. 27 indexed citations
16.
Lee, Bo Bin, Eun Ju Lee, Ho-Kyung Chun, et al.. (2009). Aberrant Methylation ofAPC, MGMT, RASSF2A, andWif-1Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer. Clinical Cancer Research. 15(19). 6185–6191. 176 indexed citations
18.
Lee, Eun Ju, Bo Bin Lee, Joungho Han, et al.. (2008). CpG island hypermethylation of E‐cadherin (CDH1) and integrin α4 is associated with recurrence of early stage esophageal squamous cell carcinoma. International Journal of Cancer. 123(9). 2073–2079. 50 indexed citations
19.
Kim, Yujin, Bo Bin Lee, Joungho Han, et al.. (2008). Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer. Cancer Letters. 274(2). 225–232. 6 indexed citations
20.
Kang, Mi Yeon, Bo Bin Lee, Young‐Ho Kim, et al.. (2007). Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. International Journal of Cancer. 121(10). 2192–2197. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026